Company intelligence / Profile preview

Eyoto

Birmingham, West Midlands, United Kingdomeyoto.com ↗

Ownership: Private
Development stage: Commercial

Overview

Eyoto has commercialized its eMap product range for rapid surface inspections of glasses and lenses. The company is developing new products enabling remote eye examinations via tele-optometry. Their technologies are used by labs and optometrists to improve efficiency and access to vision care.

Therapeutic areas: Ophthalmology
Modalities: DeviceSoftware (including AI and machine learning platforms for ophthalmic applications)
Industry: Digital Health Medical Devices

Partnerships

Working with large healthcare organizations and governing bodies such as the MHRA (Medicines & Healthcare products Regulatory Agency) and GOC (General Optical Council)

Beyond the preview

Go deeper on Eyoto.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eyoto.

Explore the full profile